COVID-19 literature surveillance-A framework to manage the literature and support evidence-based decision-making on a rapidly evolving public health topic.

COVID-19 SARS-CoV-2 evidence synthesis evidence-based decision-making knowledge synthesis literature surveillance

Journal

Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729

Informations de publication

Date de publication:
05 Jan 2023
Historique:
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: epublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has led to a rapid surge of literature on severe acute respiratory syndrome coronavirus 2 and the wider impacts of the pandemic. Research on COVID-19 has been produced at an unprecedented rate, and the ability to stay on top of the most relevant evidence is top priority for clinicians, researchers, public health professionals and policymakers. This article presents a knowledge synthesis methodology developed and used by the Public Health Agency of Canada for managing and maintaining a literature surveillance system to identify, characterize, categorize and disseminate COVID-19 evidence daily. The Daily Scan of COVID-19 Literature project comprised a systematic process involving four main steps: literature search; screening for relevance; classification and summarization of studies; and disseminating a daily report. As of the end of March 2022 there were approximately 300,000 COVID-19 and pandemic-related citations in the COVID-19 database, of which 50%-60% were primary research. Each day, a report of all new COVID-19 citations, literature highlights and a link to the updated database was generated and sent to a mailing list of over 200 recipients including federal, provincial and local public health agencies and academic institutions. This central repository of COVID-19 literature was maintained in real time to aid in accelerated evidence synthesis activities and support evidence-based decision-making during the pandemic response in Canada. This systematic process can be applied to future rapidly evolving public health topics that require the continuous evaluation and dissemination of evidence.

Sections du résumé

Background UNASSIGNED
The coronavirus disease 2019 (COVID-19) pandemic has led to a rapid surge of literature on severe acute respiratory syndrome coronavirus 2 and the wider impacts of the pandemic. Research on COVID-19 has been produced at an unprecedented rate, and the ability to stay on top of the most relevant evidence is top priority for clinicians, researchers, public health professionals and policymakers. This article presents a knowledge synthesis methodology developed and used by the Public Health Agency of Canada for managing and maintaining a literature surveillance system to identify, characterize, categorize and disseminate COVID-19 evidence daily.
Methods UNASSIGNED
The Daily Scan of COVID-19 Literature project comprised a systematic process involving four main steps: literature search; screening for relevance; classification and summarization of studies; and disseminating a daily report.
Results UNASSIGNED
As of the end of March 2022 there were approximately 300,000 COVID-19 and pandemic-related citations in the COVID-19 database, of which 50%-60% were primary research. Each day, a report of all new COVID-19 citations, literature highlights and a link to the updated database was generated and sent to a mailing list of over 200 recipients including federal, provincial and local public health agencies and academic institutions.
Conclusion UNASSIGNED
This central repository of COVID-19 literature was maintained in real time to aid in accelerated evidence synthesis activities and support evidence-based decision-making during the pandemic response in Canada. This systematic process can be applied to future rapidly evolving public health topics that require the continuous evaluation and dissemination of evidence.

Identifiants

pubmed: 36815866
doi: 10.14745/ccdr.v49i01a02
pii: 490102
pmc: PMC9902036
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5-9

Déclaration de conflit d'intérêts

Competing interests: None.

Références

Syst Rev. 2016 Feb 10;5:28
pubmed: 26864942
Nucleic Acids Res. 2021 Jan 8;49(D1):D1534-D1540
pubmed: 33166392
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
BMC Med Res Methodol. 2016 Feb 09;16:15
pubmed: 26857112
PLoS Negl Trop Dis. 2017 Jan 19;11(1):e0005132
pubmed: 28103326
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
Syst Rev. 2019 Dec 14;8(1):325
pubmed: 31837703

Auteurs

Tricia Corrin (T)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Dima Ayache (D)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Austyn Baumeister (A)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Kaitlin Young (K)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Kusala Pussegoda (K)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Rukshanda Ahmad (R)

Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Infectious Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON.

Lisa Waddell (L)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Classifications MeSH